Detalhe da pesquisa
1.
Takotsubo Syndrome during Pertuzumab and Trastuzumab Therapy for HER2-Positive Metastatic Breast Cancer.
Biomedicines
; 12(1)2024 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38255284
2.
Role of Breast Cancer Risk Estimation Models to Identify Women Eligible for Genetic Testing and Risk-Reducing Surgery.
Biomedicines
; 12(4)2024 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38672070
3.
Role of the Molecular Tumor Board for the Personalized Treatment of Patients with Metastatic Breast Cancer: A Focus on the State of the Art in Italy.
Cancers (Basel)
; 15(6)2023 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36980613
4.
Concurrent RAS and RAS/BRAF V600E Variants in Colorectal Cancer: More Frequent Than Expected? A Case Report.
Front Oncol
; 12: 863639, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35463316
5.
Anthracycline-Free Neoadjuvant Treatment in Patients with HER2-Positive Breast Cancer: Real-Life Use of Pertuzumab, Trastuzumab and Taxanes Association with an Exploratory Analysis of PIK3CA Mutational Status.
Cancers (Basel)
; 14(12)2022 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35740668
6.
Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study.
Front Oncol
; 11: 712053, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34778029
7.
Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index.
Eur J Cancer
; 142: 18-28, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33212418
8.
Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: a multicenter real-life study.
Sci Rep
; 10(1): 1456, 2020 01 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31996766